Enrolling by invitationPhase 3NCT04275232
Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis
Studying Hypoplasminogenemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Dorothy Bautista, MD
- Principal Investigator
- Dorothy V Bautista, MDMemorial University of Newfoundland
- Intervention
- Allogenic plasma aliquots, a source of plasminogen(biological)
- Enrollment
- 1 enrolled
- Eligibility
- FEMALE
- Timeline
- 2025 – 2025
Study locations (1)
- Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada
Collaborators
Canadian Blood Services
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04275232 on ClinicalTrials.govOther trials for Hypoplasminogenemia
Additional recruiting or active studies for the same condition.